These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1497 related items for PubMed ID: 16537832

  • 21. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.
    Kim TY, Jong HS, Song SH, Dimtchev A, Jeong SJ, Lee JW, Kim TY, Kim NK, Jung M, Bang YJ.
    Oncogene; 2003 Jun 19; 22(25):3943-51. PubMed ID: 12813468
    [Abstract] [Full Text] [Related]

  • 22. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y, Fatima N, Dufau ML.
    Mol Cell Biol; 2005 Sep 19; 25(18):7929-39. PubMed ID: 16135786
    [Abstract] [Full Text] [Related]

  • 23. Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer.
    Chen H, Suzuki M, Nakamura Y, Ohira M, Ando S, Iida T, Nakajima T, Nakagawara A, Kimura H.
    Oncol Rep; 2006 May 19; 15(5):1281-5. PubMed ID: 16596198
    [Abstract] [Full Text] [Related]

  • 24. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP, Harya NS, Hutzley J, Bacich DJ, Monzon FA, Chandran U, Dhir R, O'Keefe DS.
    Prostaglandins Other Lipid Mediat; 2007 Jan 19; 82(1-4):185-97. PubMed ID: 17164146
    [Abstract] [Full Text] [Related]

  • 25. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.
    Bennett KL, Hackanson B, Smith LT, Morrison CD, Lang JC, Schuller DE, Weber F, Eng C, Plass C.
    Cancer Res; 2007 May 15; 67(10):4657-64. PubMed ID: 17510391
    [Abstract] [Full Text] [Related]

  • 26. Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer.
    Kikuchi S, Yamada D, Fukami T, Masuda M, Sakurai-Yageta M, Williams YN, Maruyama T, Asamura H, Matsuno Y, Onizuka M, Murakami Y.
    Clin Cancer Res; 2005 Apr 15; 11(8):2954-61. PubMed ID: 15837747
    [Abstract] [Full Text] [Related]

  • 27. IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer.
    Ibanez de Caceres I, Cortes-Sempere M, Moratilla C, Machado-Pinilla R, Rodriguez-Fanjul V, Manguán-García C, Cejas P, López-Ríos F, Paz-Ares L, de CastroCarpeño J, Nistal M, Belda-Iniesta C, Perona R.
    Oncogene; 2010 Mar 18; 29(11):1681-90. PubMed ID: 20023704
    [Abstract] [Full Text] [Related]

  • 28. CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration.
    Bhakat KK, Mitra S.
    Carcinogenesis; 2003 Aug 18; 24(8):1337-45. PubMed ID: 12807730
    [Abstract] [Full Text] [Related]

  • 29. Effects of the histone deacetylase inhibitor trichostatin A on nuclear texture and c-jun gene expression in drug-sensitive and drug-resistant human H69 lung carcinoma cells.
    El-Khoury V, Gomez D, Liautaud-Roger F, Trussardi-Régnier A, Dufer J.
    Cytometry A; 2004 Dec 18; 62(2):109-17. PubMed ID: 15517561
    [Abstract] [Full Text] [Related]

  • 30. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
    Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K, Adachi Y, Endo T, Imai K, Shinomura Y.
    Oncogene; 2005 Nov 24; 24(53):7946-52. PubMed ID: 16007117
    [Abstract] [Full Text] [Related]

  • 31. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.
    Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD, Gazdar AF.
    Cancer Res; 2001 Jun 01; 61(11):4556-60. PubMed ID: 11389090
    [Abstract] [Full Text] [Related]

  • 32. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
    Stirzaker C, Song JZ, Davidson B, Clark SJ.
    Cancer Res; 2004 Jun 01; 64(11):3871-7. PubMed ID: 15172996
    [Abstract] [Full Text] [Related]

  • 33. C/EBPα and PU.1 are involved in distinct differentiation responses of acute promyelocytic leukemia HL-60 and NB4 cells via chromatin remodeling.
    Savickiene J, Treigyte G, Vistartaite G, Tunaitis V, Magnusson KE, Navakauskiene R.
    Differentiation; 2011 Jan 01; 81(1):57-67. PubMed ID: 20864248
    [Abstract] [Full Text] [Related]

  • 34. Cyclin D1 gene activation in human myeloma cells is independent of DNA hypomethylation or histone hyperacetylation.
    Krieger S, Grunau C, Sabbah M, Sola B.
    Exp Hematol; 2005 Jun 01; 33(6):652-9. PubMed ID: 15911089
    [Abstract] [Full Text] [Related]

  • 35. Suppression of thymidine phosphorylase expression by promoter methylation in human cancer cells lacking enzyme activity.
    Guarcello V, Blanquicett C, Naguib FN, El Kouni MH.
    Cancer Chemother Pharmacol; 2008 Jun 01; 62(1):85-96. PubMed ID: 17805539
    [Abstract] [Full Text] [Related]

  • 36. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
    Zhao W, Soejima H, Higashimoto K, Nakagawachi T, Urano T, Kudo S, Matsukura S, Matsuo S, Joh K, Mukai T.
    J Biochem; 2005 Mar 01; 137(3):431-40. PubMed ID: 15809347
    [Abstract] [Full Text] [Related]

  • 37. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
    Gery S, Tanosaki S, Bose S, Bose N, Vadgama J, Koeffler HP.
    Clin Cancer Res; 2005 May 01; 11(9):3184-90. PubMed ID: 15867211
    [Abstract] [Full Text] [Related]

  • 38. Reduced transcription of the RB2/p130 gene in human lung cancer.
    Xue Jun H, Gemma A, Hosoya Y, Matsuda K, Nara M, Hosomi Y, Okano T, Kurimoto F, Seike M, Takenaka K, Yoshimura A, Toyota M, Kudoh S.
    Mol Carcinog; 2003 Nov 01; 38(3):124-9. PubMed ID: 14587097
    [Abstract] [Full Text] [Related]

  • 39. Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer.
    Nakagawachi T, Soejima H, Urano T, Zhao W, Higashimoto K, Satoh Y, Matsukura S, Kudo S, Kitajima Y, Harada H, Furukawa K, Matsuzaki H, Emi M, Nakabeppu Y, Miyazaki K, Sekiguchi M, Mukai T.
    Oncogene; 2003 Dec 04; 22(55):8835-44. PubMed ID: 14647440
    [Abstract] [Full Text] [Related]

  • 40. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer.
    Wang LG, Beklemisheva A, Liu XM, Ferrari AC, Feng J, Chiao JW.
    Mol Carcinog; 2007 Jan 04; 46(1):24-31. PubMed ID: 16921492
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 75.